Chinese herbal medicine for treating pulmonary diseases

Abstract

The invention discloses a Chinese herbal medicine for treating pulmonary diseases. Each dose of the Chinese herbal medicine contains the following raw medicines in proportions by weight: 6-12g of cassytha filiformis, 6-15g of mulberry leaf, 10-20g of houttuynia, 6-12g of impatiens chinensis, 6-12g of ficus simplicissima lour and 3-10g of berchemia lineata. According to the ancestral prescription, the inventor makes an improvement on the basis of ''a medicine for treating pulmonary diseases-Feijiling'' invented by the inventor previously, i.e. the cassytha filiformis and the mulberry leaf are added. The Chinese herbal medicine disclosed by the invention can be used for effectively curing pneumonia, pulmonary abscess and pulmonary tuberculosis, has an effect on treating pleuritis or pleural effusion and drug-tolerant pulmonary tuberculosis complicated with pulmonary diseases, has the advantages of short course of treatment, wide raw medicine sources, low cost and no obvious toxic side effects, and can effectively relieve the burden and pain of patients.

Description

technical field [0001] The invention relates to the field of treating lung diseases, in particular to a Chinese herbal medicine for treating lung diseases. Background technique [0002] At present, Western medicines are mostly used in the treatment of lung diseases. However, Western medicines have relatively large toxic and side effects, and long-term use will have an impact on health. For example, remyphen and rifampicin can damage the liver, and streptomycin is more toxic to the fetus. The inventor's previous patent application "a medicine for treating lung diseases——Fejiling" (application number 97103551.2 published on November 5, 1997) discloses a Chinese herbal medicine for the treatment of pneumonia, lung abscess and tuberculosis. It has good curative effect, low drug cost, simple prescription and no obvious side effects. However, it is helpless for pleurisy or pleural effusion complicated by lung diseases and drug-resistant tuberculosis. Contents of the invention ...

AI Technical Summary

Problems solved by technology

[0002] At present, Western medicines are mostly used in the treatment of lung diseases. However, Western medicines have relatively large toxic and side effects, and long-term use will have an impact on health. For example, remyclofen and rifampicin will damage the liver, and streptomycin is more toxic to the fetus.

The inventor's previous patent application "a medicine for treating lung disease - Feijiling" (application number 97103551.2 published on November 5, 1997) disclosed a Chinese herbal medicine for treating pneumonia, lung abscess and pulmonary tuberculosis. Good curative effect, low drug cost, simple formula and no obvious side effects, but powerless against pleurisy or pleural effusion complicated by lung disease and drug-resistant tuberculosis